The following is a reconciliation of basic common shares outstanding to diluted common and common equivalent shares outstanding: | | | | | | | | | | | | | | | | | Fiscal quarter ended | | | | March 29, 2025 | | March 30, 2024 | | | | | | Weighted-average number of common and common equivalent shares outstanding: | | | | | | | | | Basic number of common shares outstanding | 35,312,090 | | | 35,860,740 | | | | | | Dilutive effect of equity awards | 1,923 | | | 3,843 | | | | | | | Diluted number of common and common equivalent shares outstanding | 35,314,013 | | | 35,864,583 | | | | | | | | | | | | | | | Earnings per share: | | | | | | | | | (dollars in thousands, except per share data) | | | | | | | | | Basic net income per common share: | | | | | | | | | Net income | $ | 15,539 | | | $ | 38,033 | | | | | | Income allocated to participating securities | (285) | | | (691) | | | | | | | Net income available to common shareholders | $ | 15,254 | | | $ | 37,342 | | | | | | | | | | | | | | | Basic net income per common share | $ | 0.43 | | | $ | 1.04 | | | | | | | | | | | | | | | Diluted net income per common share: | | | | | | | | | Net income | $ | 15,539 | | | $ | 38,033 | | | | | | Income allocated to participating securities | (285) | | | (691) | | | | | | | Net income available to common shareholders | $ | 15,254 | | | $ | 37,342 | | | | | | | | | | | | | | | Diluted net income per common share | $ | 0.43 | | | $ | 1.04 | | | | | | | | | | | | | | Anti-dilutive awards excluded from diluted earnings per share computation(*) | 389,307 | | | 448,870 | | | | | |
(*)The volume of anti-dilutive awards is, in part, due to the related unamortized compensation costs.
|